1. abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración
  2. Track

abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración

Primary tabs

Time ReferrerUserOperations
09/16/2025 - 07:00node/7427/trackAnonymous (not verified)details
09/16/2025 - 06:31node/7427/trackAnonymous (not verified)details
09/15/2025 - 23:56node/7427/trackAnonymous (not verified)details
09/15/2025 - 03:11node/7427/trackAnonymous (not verified)details
09/14/2025 - 22:32node/7427/trackAnonymous (not verified)details
09/14/2025 - 18:36node/7427/trackAnonymous (not verified)details
09/14/2025 - 17:45node/7427/trackAnonymous (not verified)details
09/14/2025 - 09:19node/7427/trackAnonymous (not verified)details
09/13/2025 - 07:58node/7427/trackAnonymous (not verified)details
09/13/2025 - 07:56node/7427/trackAnonymous (not verified)details